{"filing":{"accession_number":"0001437749-26-021495","cik":"0001617867","ticker":"AMIX","company_name":"Autonomix Medical, Inc.","form":"8-K","filing_date":"2026-06-24","report_date":null,"primary_document":"amix20260619_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1617867/000143774926021495/amix20260619_8k.htm"},"events":[{"id":13353,"run_id":11860,"accession_number":"0001437749-26-021495","anchor_item_number":"5.03","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Autonomix Medical implemented a 1-for-21 reverse stock split effective June 24, 2026, reducing outstanding shares from approximately 11.4 million to 543,000. The reverse split was approved by stockholders at the October 30, 2025 annual meeting and effected through an amendment to the certificate of incorporation filed with Delaware, materially affecting share ownership percentages, voting power, and trading mechanics.","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-06-24","form":"8-K","submitted_at":null,"items":[{"id":10470,"accession_number":"0001437749-26-021495","item_number":"3.03","item_title":"Material Modifications of Rights of Security Holders","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing discloses a 1-for-21 reverse stock split effective June 24, 2026, which materially modifies the rights and economic interests of security holders by consolidating shares and reducing outstanding shares from approximately 11.4 million to 543,000. While this is a governance/capital structure event rather than a specific named category, it is clearly material to investors as it affects share ownership percentages, voting power, and trading mechanics. The Item 3.03 reference to Item 5.03 indicates this is a charter/bylaw amendment matter, making governance_other the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T11:01:46.297915+00:00","company_name":"","ticker":null,"filing_date":""},{"id":10471,"accession_number":"0001437749-26-021495","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure reports the implementation of a 1-for-21 reverse stock split approved by stockholders at the October 30, 2025 annual meeting and effectuated on June 24, 2026. While Item 5.03 covers amendments to articles of incorporation and bylaws, the substance here is a governance/capital structure action—a reverse stock split—that materially affects share structure (reducing outstanding shares from ~11.4 million to ~543,000) and is material to investors assessing the company's capitalization and trading mechanics. This is a governance event rather than a specific named type like exec_appointment or exec_departure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T11:01:46.297915+00:00","company_name":"","ticker":null,"filing_date":""},{"id":10472,"accession_number":"0001437749-26-021495","item_number":"8.01","item_title":"Other Events","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The disclosure announces a 1-for-21 reverse stock split effected through an amendment to the certificate of incorporation filed with Delaware. This is a governance event involving a capital structure change that affects all shareholders' holdings and the company's outstanding share count (from ~11.4 million to ~543,000 shares). While reverse splits are often associated with delisting risk or financial distress, the filing does not explicitly disclose a delisting notice or failure to meet listing standards; it is presented as a corporate action. The event is material to investors as it fundamentally alters share ownership percentages and per-share metrics.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T11:01:46.297915+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10470,"accession_number":"0001437749-26-021495","item_number":"3.03","item_title":"Material Modifications of Rights of Security Holders","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing discloses a 1-for-21 reverse stock split effective June 24, 2026, which materially modifies the rights and economic interests of security holders by consolidating shares and reducing outstanding shares from approximately 11.4 million to 543,000. While this is a governance/capital structure event rather than a specific named category, it is clearly material to investors as it affects share ownership percentages, voting power, and trading mechanics. The Item 3.03 reference to Item 5.03 indicates this is a charter/bylaw amendment matter, making governance_other the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T11:01:46.297915+00:00","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-06-24"},{"id":10471,"accession_number":"0001437749-26-021495","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure reports the implementation of a 1-for-21 reverse stock split approved by stockholders at the October 30, 2025 annual meeting and effectuated on June 24, 2026. While Item 5.03 covers amendments to articles of incorporation and bylaws, the substance here is a governance/capital structure action—a reverse stock split—that materially affects share structure (reducing outstanding shares from ~11.4 million to ~543,000) and is material to investors assessing the company's capitalization and trading mechanics. This is a governance event rather than a specific named type like exec_appointment or exec_departure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T11:01:46.297915+00:00","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-06-24"},{"id":10472,"accession_number":"0001437749-26-021495","item_number":"8.01","item_title":"Other Events","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The disclosure announces a 1-for-21 reverse stock split effected through an amendment to the certificate of incorporation filed with Delaware. This is a governance event involving a capital structure change that affects all shareholders' holdings and the company's outstanding share count (from ~11.4 million to ~543,000 shares). While reverse splits are often associated with delisting risk or financial distress, the filing does not explicitly disclose a delisting notice or failure to meet listing standards; it is presented as a corporate action. The event is material to investors as it fundamentally alters share ownership percentages and per-share metrics.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-24T11:01:46.297915+00:00","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-06-24"}]}